UPDATE : Thursday, August 6, 2020
KDA tells patients not to stop taking metformin arbitrarily
The Korean Diabetes Association (KDA) has warned diabetic patients against ...
by Lee Han-soo  |  2019-12-16 10:56
GC, Add Pharma to co-develop synthetic drugs
GC said that it has agreed with Add Pharmaceutical to cooperate on developi...
by Lee Han-soo  |  2019-12-13 16:25
Daewoong releases trial results for autoimmune disease treatment candidate
Daewoong Pharmaceutical said that it has presented the research results of ...
by Lee Han-soo  |  2019-12-13 15:12
GC Labcell releases trial results of NK-cell combination treatment
GC Labcell has presented the preclinical trial data for new blood cancer tr...
by Lee Han-soo  |  2019-12-12 18:00
Eli Lilly Korea launches migraine prevention drug
Eli Lilly said that it has officially launched Emgality, a migraine prevent...
by Lee Han-soo  |  2019-12-12 15:28
Sanofi releases new meta-analysis data for diabetes treatment Soliqua
Sanofi said that it has presented the results of a new network meta-analysi...
by Lee Han-soo  |  2019-12-12 15:01
Hanmi unveils new data at American Society of Hematology
Hanmi Pharmaceutical said that it has presented clinical trial results for ...
by Lee Han-soo  |  2019-12-12 14:17
Bayer Korea names Freda Lin as new president
Bayer Korea announced that it has appointed Freda Lin as its new president,...
by Lee Han-soo  |  2019-12-12 14:16
SK Bioscience's chickenpox vaccine world's 2nd to get WHO’s PQ certification
SK Bioscience said its Sky Varicella has become the world's second chic...
by Lee Han-soo  |  2019-12-11 15:30
ABL Bio unveils new bispecific antibody at US meet
ABL Bio said that it has introduced a B-cell maturation antigen (BCMA)x4-1B...
by Lee Han-soo  |  2019-12-10 18:12
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
Hanmi Pharmaceutical and Sanofi are looking for a new partner to commercial...
by Lee Han-soo  |  2019-12-10 11:43
Samyang Biopharma USA, Talix Therapeutics to co-develop immunotherapy candidates
Samyang Biopharm USA said Tuesday it has signed a deal to develop a new imm...
by Lee Han-soo  |  2019-12-10 11:43
AbbVie's releases new data for chronic lymphocytic leukemia treatment
AbbVie has presented new long-term data, further supporting the sustained c...
by Lee Han-soo  |  2019-12-09 17:42
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
Medipost said Japan's Ministry of Health, Labour and Welfare has approv...
by Lee Han-soo  |  2019-12-09 16:15
Will partial success of Biogen’s Alzheimer’s drug lead to FDA approval?
As preannounced by Biogen in October, its Alzheimer's drug candidate ad...
by Kim Yun-mi  |  2019-12-09 14:39
New MSD labor union launched with fresh resolve
A new MSD Korea labor union has kicked off. The new union consists of emplo...
by Jeong Sae-im  |  2019-12-09 14:37
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
Gemvax & Kael said that it presented the results of phase 2 clinical trial ...
by Lee Han-soo  |  2019-12-06 17:06
AbbVie’s Venclexta nears insurance benefit
AbbVie Korea’s Venclexta Tab. (ingredient: venetoclax), a drug for recurren...
by Kim Eun-young  |  2019-12-06 16:35
Syntekabio, CHA Hospital to co-develop immunotherapy
Syntekabio said that it will develop immunotherapy agents jointly with CHA ...
by Lee Han-soo  |  2019-12-06 16:32
Medpacto vows to become global company specializing in biomarker-based drugs
Medpacto, a subsidiary of Theregen ETEX, plans to develop Vactosertib, an i...
by Lee Han-soo  |  2019-12-06 15:03
Back to Top